UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1728-1733

2001

Volltextzugriff (PDF)

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin

Cancer, 2003-10, Vol.98 (7), p.1514-1520

2003

Volltextzugriff (PDF)

Intermittent Erlotinib in Combination with Pemetrexed: Phase I Schedules Designed to Achieve Pharmacodynamic Separation

Journal of thoracic oncology, 2009-07, Vol.4 (7), p.862-868

2009

Volltextzugriff (PDF)

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group

Gynecologic oncology, 2005-03, Vol.96 (3), p.610-615

2005

Volltextzugriff (PDF)

Tamoxifen, hot flashes and recurrence in breast cancer

Breast cancer research and treatment, 2008-04, Vol.108 (3), p.421-426

2008

Volltextzugriff (PDF)

Reproductive Steroid Hormones and Recurrence-Free Survival in Women with a History of Breast Cancer

Cancer epidemiology, biomarkers & prevention, 2008-03, Vol.17 (3), p.614-620

2008

Volltextzugriff (PDF)

Longitudinal Biological Exposure to Carotenoids Is Associated with Breast Cancer–Free Survival in the Women's Healthy Eating and Living Study

Cancer epidemiology, biomarkers & prevention, 2009-02, Vol.18 (2), p.486-494

2009

Volltextzugriff (PDF)

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study

Gynecologic oncology, 2004-07, Vol.94 (1), p.98-106

2004

Volltextzugriff (PDF)

Increased Incidence of Symptomatic Venous Thrombosis in Patients With Cervical Carcinoma Treated With Concurrent Chemotherapy, Radiation, and Erythropoietin

Obstetrical & gynecological survey, 2004-01, Vol.59 (1), p.34-35

2004

Volltextzugriff (PDF)

Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients

Journal of reproductive medicine, 2006-05, Vol.51 (5), p.383

2006

Volltextzugriff (PDF)

Reliability of Plasma Carotenoid Biomarkers and Its Relation to Study Power

Epidemiology (Cambridge, Mass.), 2008-03, Vol.19 (2), p.338-344

2008

Volltextzugriff (PDF)

Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21 [formula omitted] predicts survival and good response to platinin-based chemotherapy

Human pathology, 1999-06, Vol.30 (6), p.640-647

1999

Volltextzugriff (PDF)

Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva

Gynecologic oncology, 1992-10, Vol.47 (1), p.14-20

1992

Volltextzugriff (PDF)

A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2

Clinical pharmacology and therapeutics, 1991-03, Vol.49 (3), p.307-313

1991

Volltextzugriff (PDF)

Osimertinib (TAGRISSO™) and the cobas® EGFR Mutation Test v2

Companion and Complementary Diagnostics, 2019

Jørgensen, Jan Trøst

2019

Volltextzugriff (PDF)

Prophylactic Chemoradiation of Inguinofemoral Lymph Nodes in Patients with Locally Extensive Vulvar Cancer

Gynecologic oncology, 1997-09, Vol.66 (3), p.509-514

1997

Volltextzugriff (PDF)

Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4)

American journal of clinical pathology, 1998-02, Vol.109 (2), p.173-180

1998

Volltextzugriff (PDF)

13-cis-Retinoic Acid or All-trans-Retinoic Acid plus Interferon-α in Recurrent Cervical Cancer: A Southwest Oncology Group Phase II Randomized Trial

Gynecologic oncology, 1998-12, Vol.71 (3), p.386-390

1998

Volltextzugriff (PDF)

Polymerase Chain Reaction

Companion and Complementary Diagnostics, 2019

Jørgensen, Jan Trøst

2019

Volltextzugriff (PDF)

Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21WAF1CIP1 predicts survival and good response to platinin-based chemotherapy

Human pathology, 1999-06, Vol.30 (6), p.640-647

1999

Volltextzugriff (PDF)

DNA Cross-linking and Cytotoxicity of the Alkylating Cyanomorpholino Derivative of Doxorubicin in Multidrug-Resistant Cells

JNCI : Journal of the National Cancer Institute, 1988-10, Vol.80 (16), p.1294-1298

1988

Volltextzugriff (PDF)

Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study

Journal of immunotherapy, 1991-02, Vol.10 (1), p.57-62

1991

Volltextzugriff (PDF)

High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group

Seminars in oncology, 1986-12, Vol.13 (4 Suppl 4), p.26

1986

Volltextzugriff (PDF)

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Journal of clinical oncology, 2008-01, Vol.26 (1), p.76-82

2008

Volltextzugriff (PDF)

Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes

PloS one, 2024-04, Vol.19 (4), p.e0295987-e0295987

2024

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(44)
Buchkapitel
(2)

Sprache

Englisch
(46)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Humans
(29)
Female
(24)
Middle Aged
(22)
Oncology
(21)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Aged
(15)
Adult
(14)
Tumors
(12)
Aged, 80 And Over
(8)
Gynecology. Andrology. Obstetrics
(8)
Obstetrics & Gynecology
(8)
Ovarian Neoplasms - Drug Therapy
(8)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Adolescent
(5)
Chemotherapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin

Intermittent Erlotinib in Combination with Pemetrexed: Phase I Schedules Designed to Achieve Pharmacodynamic Separation

Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group

Tamoxifen, hot flashes and recurrence in breast cancer

Reproductive Steroid Hormones and Recurrence-Free Survival in Women with a History of Breast Cancer

Longitudinal Biological Exposure to Carotenoids Is Associated with Breast Cancer–Free Survival in the Women's Healthy Eating and Living Study

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study

Increased Incidence of Symptomatic Venous Thrombosis in Patients With Cervical Carcinoma Treated With Concurrent Chemotherapy, Radiation, and Erythropoietin

Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients

Reliability of Plasma Carotenoid Biomarkers and Its Relation to Study Power

Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21 [formula omitted] predicts survival and good response to platinin-based chemotherapy

Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva

A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2

Osimertinib (TAGRISSO™) and the cobas® EGFR Mutation Test v2

Prophylactic Chemoradiation of Inguinofemoral Lymph Nodes in Patients with Locally Extensive Vulvar Cancer

Clinicopathologic significance of transitional cell carcinoma pattern in nonlocalized ovarian epithelial tumors (stages 2-4)

13-cis-Retinoic Acid or All-trans-Retinoic Acid plus Interferon-α in Recurrent Cervical Cancer: A Southwest Oncology Group Phase II Randomized Trial

Polymerase Chain Reaction

Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21WAF1CIP1 predicts survival and good response to platinin-based chemotherapy

DNA Cross-linking and Cytotoxicity of the Alkylating Cyanomorpholino Derivative of Doxorubicin in Multidrug-Resistant Cells

Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study

High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes

Suchergebnisse filtern